DBVT DBV Technologies Total Debt to Capital

DBV Technologies S.A. (DBVT) creates innovative patches to combat severe allergies, leveraging the patent protection of its methods. The asset value of 0.13 shown on this chart demonstrates the company's financial profile. The business implements sustainable standards in production and strictly adheres to bioethics in waste disposal, which minimizes environmental impact and strengthens its market position.

DBV Technologies S.A. (DBVT) is expanding the long-term allergy therapy market through proprietary consumables. This metric quantifies the dependence of such investments on borrowed funds relative to equity. The ratio measures the degree of financial leverage, determining the company's resilience to liquidity shortages. High values signal over-leverage risks, while low values indicate conservative resource management. By analyzing the ratio of financial liabilities to equity, an investor assesses the balance between debt load and business autonomy.